...
首页> 外文期刊>The Internet journal of allied health sciences practice >Effectiveness of hydrotherapy as an adjunct treatment for the management of breast cancer related lymphoedema in women following breast cancer surgery: a systematic review
【24h】

Effectiveness of hydrotherapy as an adjunct treatment for the management of breast cancer related lymphoedema in women following breast cancer surgery: a systematic review

机译:水疗法作为乳腺癌手术后妇女与乳腺癌相关的淋巴水肿管理的辅助治疗的有效性:系统评价

获取原文
           

摘要

Cancer is a leading cause of death and disability around the world. Of all cancers, breast cancer commonly ranks amongst the top three. Surgical intervention for breast cancer is common and a possible side effect of this is breast cancer related lymphoedema (BCRL). Women with breast cancer related lymphoedema commonly have regional limb swelling and pain, which can negatively impact mental and social well-being as well as upper limb function. Hydrotherapy is therapeutic modality which may be used as an adjunct to self-management strategies after the intensive phase of lymphoedema management. Yet despite its popularity, recent research has questioned its effectiveness in clinical practice. Purpose: To determine the effectiveness of hydrotherapy as an adjunct treatment to usual care on arm volume and pain when compared with usual care alone for women with breast cancer related lymphoedema. Method: A comprehensive search of eight electronic databases, including Medline, Embase, CINAHL, Scopus, Web of Science, AMED, The Cochrane Library and PEDro was completed. Studies of adult women with secondary upper limb lymphoedema following breast cancer surgery, which measured lymphoedema volume, pain, upper limb and QOL outcomes were included. Methodological quality was assessed using a modified CASP tool for randomised controlled trials. The NHMRC FORM methodology was utilised to synthesise the evidence and provide an overall grade of recommendation. Results: Four randomised controlled trials and one controlled clinical trial were included in this systematic review. Critical appraisal of the included studies revealed overall methodological quality to be moderate. Hydrotherapy interventions duration varied between 8 to 12 weeks with some similarities between outcome measures assessed. Collectively, there is mixed evidence to support the positive impact of hydrotherapy as an adjunct treatment on reducing lymphoedema volume in the short-term and emerging evidence for upper limb function, pain and QOL. Conclusion: A small number of studies have investigated the effect of hydrotherapy as an adjunct treatment in the breast cancer related lymphoedema population. Hydrotherapy could be considered as an adjunct treatment for women with breast cancer related lymphoedema, although the evidence base is mixed. Hydrotherapy may have positive physiological as well psychosocial impacts, as it is delivered in a group setting. However, the current literature base is limited by small sample size, lack of standardised exercise parameters, inadequate baseline characteristic assessment and limited long-term follow-up.
机译:癌症是世界范围内导致死亡和残疾的主要原因。在所有癌症中,乳腺癌通常位居前三名。乳腺癌的外科手术治疗很常见,其可能的副作用是乳腺癌相关的淋巴水肿(BCRL)。患有乳腺癌相关淋巴水肿的女性通常会出现局部肢体肿胀和疼痛,这会对心理和社会福祉以及上肢功能产生负面影响。水疗是一种治疗方式,可以在强化淋巴水肿治疗阶段后用作自我管理策略的辅助手段。尽管它很受欢迎,但最近的研究对它在临床实践中的有效性提出了质疑。目的:与患有乳腺癌相关淋巴水肿的妇女单独进行常规治疗相比,确定水疗作为常规治疗的辅助方法在手臂容量和疼痛方面的辅助治疗的有效性。方法:完成了对八个电子数据库的全面搜索,包括Medline,Embase,CINAHL,Scopus,Web of Science,AMED,Cochrane图书馆和PEDro。包括对乳腺癌手术后继发上肢继发性水肿的成年女性进行的研究,该研究测量了淋巴水肿的量,疼痛,上肢和QOL结果。方法学质量使用改良的CASP工具进行随机对照试验评估。 NHMRC FORM方法用于综合证据并提供总体推荐等级。结果:该系统评价包括四项随机对照试验和一项对照临床试验。对纳入研究的严格评估显示总体方法学质量中等。水疗干预的持续时间在8到12周之间变化,评估的结果指标之间也有相似之处。总体上,有混合的证据支持短期内使用水疗作为辅助治疗对减少淋巴水肿量的积极影响,有关上肢功能,疼痛和QOL的新证据。结论:少数研究调查了水疗法作为乳腺癌相关淋巴水肿人群的辅助治疗方法的效果。尽管证据混杂,但水疗可被认为是患有乳腺癌相关淋巴水肿的女性的辅助治疗方法。由于水疗是在小组中进行的,因此可能会对生理和社会心理产生积极影响。但是,当前的文献基础受到样本量小,缺乏标准化运动参数,基线特征评估不足和长期随访的限制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号